Therapy Response Imaging in Lymphoma and Hematologic Malignancies

Hematologic malignancies are a heterogeneous group of disorders characterized by a clonal proliferation of abnormal cells in the bone marrow and lymphoid tissues and are divided into two major categories, lymphoid and myeloid. Imaging is most commonly used for staging and response evaluations in lymphoid malignancies, of which there are over 90 subtypes (Swerdlow SH, Campo E, Pileri SA, Blood 127:2375–2390, 2016).